Cargando…

Data‐driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine

Linked Article: Geifman et al. Br J Dermatol 2021; 185:825–835.

Detalles Bibliográficos
Autores principales:	van der Schoot, L. S., van den Reek, J. M. P. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518914/ https://www.ncbi.nlm.nih.gov/pubmed/34337747 http://dx.doi.org/10.1111/bjd.20625

Ejemplares similares

Predicting treatment success with biologics in psoriasis
por: van den Reek, J.M.P.A.
Publicado: (2019)

Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
por: van der Schoot, L. S., et al.
Publicado: (2023)

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide
por: van Muijen, M. E., et al.
Publicado: (2021)

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice
por: van der Schoot, L.S., et al.
Publicado: (2023)

CARD14 mutations may predict response to antitumour necrosis factor‐α therapy in psoriasis: a potential further step towards personalized medicine
por: Wu, K.C.P., et al.
Publicado: (2016)

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice
por: ATALAY, Selma, et al.
Publicado: (2021)

Toward a precision medicine approach for autoimmunity
por: Kissler, Stephan
Publicado: (2022)

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
por: van der Schoot, Lara S., et al.
Publicado: (2022)

Putting data to work for precision medicine
por: Bjerrum, Andreas, et al.
Publicado: (2023)

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine
por: Felice, Carla, et al.
Publicado: (2019)

Circular RNA in liquid biopsy as biomarkers toward precision medicine
por: Lee, Yueh-Chun, et al.
Publicado: (2023)

Why “sex as a biological variable” conflicts with precision medicine initiatives
por: DiMarco, Marina, et al.
Publicado: (2022)

Data-driven precision medicine through the analysis of biological functional modules
por: Shomorony, Ilan
Publicado: (2022)

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
por: van der Schoot, Lara S., et al.
Publicado: (2021)

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
por: Calzetta, Luigino, et al.
Publicado: (2017)

4 Ds in health research—working together toward rapid precision medicine
por: Niederberger, Ellen, et al.
Publicado: (2019)

Precision medicine driven by cancer systems biology
por: Filipp, Fabian V.
Publicado: (2017)

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
por: Michielsens, C. A. J., et al.
Publicado: (2021)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine?
por: Ravegnini, Gloria, et al.
Publicado: (2019)

Why rare disease needs precision medicine—and precision medicine needs rare disease
por: Might, Matthew, et al.
Publicado: (2022)

Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards precision medicine?
por: von Groote, Thilo, et al.
Publicado: (2022)

Capturing phenotypes for precision medicine
por: Robinson, Peter N., et al.
Publicado: (2015)

‘En route’ to precision medicine
por: Hijnen, D.J.
Publicado: (2019)

Experimental pharmacology in precision medicine
por: Urbaniak, Alicja, et al.
Publicado: (2023)

Pharmaco-omics data sheds light on therapy-oriented prospects of precision medicine
por: Zheng, Jie, et al.
Publicado: (2021)

Data driven precision medicine: who is the driver?
por: Klein, Sebastian, et al.
Publicado: (2021)

Translational research identifies a metabolism pathway involved in first-episode of schizophrenia: Towards precision medicine
por: Simonneau, Michel
Publicado: (2019)

The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine
por: Tingen, Hendrea Sanne Aletta, et al.
Publicado: (2023)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG
por: Gandjour, Afschin
Publicado: (2020)

Precision Medicine in Non-Communicable Diseases
por: Novelli, Giuseppe, et al.
Publicado: (2020)

Causes of early-onset type 1 diabetes: toward data-driven environmental approaches
por: Bougnères, Pierre, et al.
Publicado: (2008)

Precision Medicine: From “Omics” to Economics towards Data-Driven Healthcare - Time for European Transformation
por: Lacombe, Denis, et al.
Publicado: (2017)

A step ahead toward precision medicine for chronic lymphocytic leukemia
por: Patriarca, Andrea, et al.
Publicado: (2020)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)

Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
por: Wu, Yichao, et al.
Publicado: (2020)

Toward a logical integrative medicine: beyond data accumulation
por: Chi, Gyoo Yong
Publicado: (2020)

A new step toward tuberculosis vaccine?
por: Tersigni, Chiara, et al.
Publicado: (2020)

Extracorporeal gas exchange in acute lung injury: step by step towards expanded indications?
por: Dembinski, Rolf, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_58pc849u8vjtdde10fj6f8usk6